<?xml version="1.0" encoding="UTF-8"?>
<p>We also compared seizure frequency, duration from onset to SDS score evaluation, and number of anti-seizure medications (ASMs) between the pre-Group and within-Group. Seizure frequency was classified as: (1) daily; (2) weekly; (3) monthly; or (4) yearly. These secondary outcomes were chosen as factors potentially related to anxiety or depressive disorders (
 <xref rid="B19" ref-type="bibr">19</xref>).
</p>
